Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors.

A pyridazin-4-one fragment 4 (hCatS IC(50)=170 microM) discovered through Tethering was modeled into cathepsin S and predicted to overlap in S2 with the tetrahydropyridinepyrazole core of a previously disclosed series of CatS inhibitors. This fragment served as a template to design pyridazin-3-one 12 (hCatS IC(50)=430 nM), which also incorporates P3 and P5 binding elements. A crystal structure of 12 bound to Cys25Ser CatS led to the synthesis of the potent diazinone isomers 22 (hCatS IC(50)=60 nM) and 27 (hCatS IC(50)=40 nM).

[1]  M. Lamers,et al.  Structure of a Cys25-->Ser mutant of human cathepsin S. , 2002, Acta crystallographica. Section D, Biological crystallography.

[2]  Lars Karlsson,et al.  Identification of a Potent and Selective Noncovalent Cathepsin S Inhibitor , 2004, Journal of Pharmacology and Experimental Therapeutics.

[3]  J. Ellman,et al.  Substrate activity screening: a fragment-based method for the rapid identification of nonpeptidic protease inhibitors. , 2005, Journal of the American Chemical Society.

[4]  Rebecca A. Roberts.  Lysosomal cysteine proteases: structure, function and inhibition of cathepsins. , 2005, Drug news & perspectives.

[5]  D. Spero,et al.  Cysteine protease cathepsin S as a key step in antigen presentation. , 2004, Drug news & perspectives.

[6]  A. Ray,et al.  Cysteine cathepsin S as an immunomodulatory target: present and future trends , 2008, Expert opinion on therapeutic targets.

[7]  R. Stroud,et al.  Site-directed ligand discovery. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Mckillop,et al.  One-pot preparation of 6-substituted 3(2H)-pyridazinones from ketones , 1993 .

[9]  A. Rudensky,et al.  Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. , 1999, Immunity.

[10]  Donald Hamelberg,et al.  Standard free energy of releasing a localized water molecule from the binding pockets of proteins: double-decoupling method. , 2004, Journal of the American Chemical Society.

[11]  C. Mackay,et al.  Gene Profiling in Atherosclerosis Reveals a Key Role for Small Inducible Cytokines: Validation Using a Novel Monocyte Chemoattractant Protein Monoclonal Antibody , 2005, Circulation.

[12]  M. Congreve,et al.  Recent developments in fragment-based drug discovery. , 2008, Journal of medicinal chemistry.

[13]  K. Clément,et al.  Emerging role of cathepsin S in obesity and its associated diseases , 2007, Clinical chemistry and laboratory medicine.

[14]  Wen Jiang,et al.  Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors. , 2005, Bioorganic & medicinal chemistry letters.

[15]  S. Bevan,et al.  Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain. , 2008, Journal of medicinal chemistry.

[16]  Y. Gong,et al.  A direct approach to the synthesis of 5-aryl-4-chloropyridazinone: From microwave assisted catalyst screen to room temperature regio- and chemoselective Suzuki arylation , 2004 .

[17]  C. Stichel,et al.  Upregulation of cathepsin S in the aging and pathological nervous system of mice , 2008, Brain Research.

[18]  J. Johnston,et al.  Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis , 2009, Clinical Cancer Research.

[19]  Wolfgang Jahnke,et al.  Fragment-based Approaches in Drug Discovery: JAHNKE: FRAGMENT-BASED APPROACHES IN DRUG DISCOVERY O-BK , 2006 .

[20]  D. Erlanson,et al.  Tethering in early target assessment , 2004 .

[21]  Renxiao Wang,et al.  Analysis of Ligand-Bound Water Molecules in High-Resolution Crystal Structures of Protein-Ligand Complexes , 2007, J. Chem. Inf. Model..

[22]  Caterina Barillari,et al.  Classification of water molecules in protein binding sites. , 2007, Journal of the American Chemical Society.

[23]  Mary Pat Beavers,et al.  Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S. , 2004, Journal of medicinal chemistry.